Senior Manager QA Operations

Company: Ipsen
Apply for the Senior Manager QA Operations
Location: London
Job Description:

Overview

As Senior Manager, QA Operations you will provide quality oversight across Ipsen’s clinical studies, partnering with R&D and cross-functional teams to ensure GCP-compliant activities. You will lead risk-based quality oversight, inspection readiness, and continuous improvement within the clinical development portfolio. The role acts as a trusted quality partner to study teams, guiding QA decisions and regulatory readiness. This is a chance to drive quality excellence in a global, matrix organisation and support innovations in oncology, rare disease, and neuroscience.

Responsibilities

  • Provide quality oversight for clinical studies and programmes across multiple therapeutic areas
  • Partner with clinical and medical teams to ensure compliance with GCP, regulatory requirements, and Ipsen quality standards
  • Provide QA expertise and guidance to cross-functional study teams
  • Support quality planning, risk management, investigations, CAPAs, and quality improvement initiatives
  • Contribute to inspection readiness, regulatory GCP inspections, audits, and quality assessments
  • Support oversight of service providers, vendors, and clinical partners
  • Promote continuous improvement across clinical and medical quality systems and processes

Key requirements

  • Significant Clinical Quality Assurance experience in pharma/biotech
  • Direct experience supporting GCP-regulated clinical studies and development programmes
  • Strong knowledge of GCP and quality oversight principles
  • Experience in quality risk management, GCP inspections (MHRA, EMA, FDA), audit planning, investigations, and CAPAs
  • Ability to collaborate and influence within a global matrix organisation
  • Master’s degree or equivalent scientific qualification
  • Fluent English
  • collaboration
  • influence within a global matrix
  • problem-solving
  • GCP
  • quality risk management
  • CAPA investigations

…

Posted: October 1st, 2026